The Complete Guide to Longevity Treatments and Healthy Aging

Written by Evergreen Editorial, Evergreen Telehealth

Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth

Published Updated

Quick Answer

Longevity treatments are approaches used to support healthy aging, from everyday habits to prescription therapies such as peptides, NAD+, GLP-1 medications, and low-dose naltrexone. Exercise, sleep, healthy eating, and preventive care have the strongest evidence. For most longevity treatments, human evidence is limited, none is proven to extend lifespan, and care should be individualized and monitored by a licensed clinician.

A smiling older couple dancing in a bright living room, the man dipping the laughing woman

Introduction

Search for "longevity" and you'll find big promises: reversed aging, extra decades, a body that never slows down. The research is more modest and a lot more interesting. Scientists have learned a great deal about why the body changes with age, and some treatments are being studied for how they affect energy, recovery, body composition, and skin. But for most of those treatments, strong evidence that they help people live longer or stay healthier longer does not yet exist.

This guide takes the careful route. It covers what longevity treatments are, how aging affects the body, what longevity medicine involves, and where each major approach stands on the evidence: peptides, GLP-1 microdosing, sermorelin, NAD+, glutathione, GHK-Cu, and low-dose naltrexone. It also covers safety, monitoring, and the lifestyle habits that remain the best-supported foundation for healthy aging.

Think of this page as the map, not the whole territory. Each topic is covered in enough depth to give you a real answer, and where a subject deserves a deeper dive, we link to a dedicated resource. Information here is educational. It does not describe pricing or program details, and it doesn't mean any treatment is right for you or available to you.

Want to see how clinician-guided longevity care works? Learn more about Evergreen Longevity →

What Are Longevity Treatments?

"Longevity treatments" is a broad, informal term. It covers any approach used with the goal of supporting healthy aging: lifestyle changes, preventive screening, and, in some clinics, prescription therapies such as peptides and other compounds. It is not a regulatory category, and no treatment on that list has been proven to extend human lifespan.

It helps to separate three ideas. Lifespan is how long you live. Healthspan is how many of those years you spend in good health, free from serious disease or disability. Healthy aging is the broader goal of staying functional, independent, and well for as long as possible. Most longevity medicine focuses on healthspan, because adding years of poor health is not what most people are looking for.

The gap between the two is real. A study of 183 World Health Organization member countries found a global average gap of 9.6 years between lifespan and healthspan in 2019, and Americans spent an average of 12.4 years in poor health, the largest gap in the study. (1) Genetics matter, but twin studies suggest they explain roughly 10% to 30% of the variation in lifespan, which leaves a lot of room for things you can influence. (2)

Want the full explanation of these terms? What Is Healthspan and How Is It Different from Lifespan? →

How Does Aging Affect the Body?

Aging is not one change but many, happening at different speeds in different systems. Several of them are the focus of longevity care:

  • Muscle and strength. Muscle mass and strength peak around ages 30 to 35 and then decline slowly, faster after about age 65 for women and 70 for men. (5) Estimates suggest muscle mass falls roughly 3% to 8% per decade after age 30, with the rate rising after age 60. (3) Researchers estimate that 10% to 20% of older adults have sarcopenia, the age-related loss of muscle mass, strength, and function. (4) Loss of muscle is linked to falls, hospitalization, and lost independence.
  • Metabolism and body composition. Changes in muscle, activity, hormones, and insulin sensitivity can shift how the body uses and stores energy. Many people notice they gain fat more easily and lose muscle more easily as they age, even with similar habits.
  • Energy and recovery. Many adults notice that stamina drops and that recovery from exercise, illness, or poor sleep takes longer. Changes in sleep, muscle, hormones, and the cell's energy-producing machinery are all thought to play a part.
  • Skin. Skin becomes thinner and drier and heals more slowly as collagen and elastin decline, and sun exposure speeds the process.

None of these changes is a disease, and none is identical from person to person. Lifestyle, genetics, and underlying conditions all affect how fast they happen. A related idea is biological age, an attempt to estimate how "old" your body is at the molecular level compared with your birth date. Biological age tests are still being validated, and their ability to predict real-world health outcomes is not settled. Biological Age vs. Chronological Age: What's the Difference? →

Learn more about each system: What Happens to Your Body as You Age? →, How Does Aging Affect Energy and Recovery? →, and Why Muscle Mass Matters for Healthy Aging →. For the metabolic basics, see What Is Metabolic Health and Why Does It Matter? →.

What Is Longevity Medicine?

Longevity medicine is a clinical approach that aims to detect risk early and support healthy aging through individualized care. There is no single, universally accepted definition, and no standardized set of guidelines for what it must include, which is one reason quality and approach vary widely between providers.

In practice, a thoughtful approach usually involves several pieces:

  • Clinical assessment. A licensed clinician reviews your health history, symptoms, medications, and goals. Lab work may be used when it is clinically appropriate, not as a routine for everyone.
  • Individualized planning. Treatments are chosen for the person, not offered as a standard package. Some people may be good candidates for a given therapy and others may not.
  • Monitoring. Follow-up matters for tracking how you feel, watching for side effects, and deciding whether to continue, adjust, or stop.
  • Realistic goals. A good plan is honest about what the evidence does and does not support. It treats foundations like exercise, sleep, nutrition, and routine preventive care as the base, and not as an afterthought.

A caution: more testing is not automatically better. Chasing biomarkers without clinical context can lead to unnecessary tests, interventions, and anxiety. Learn more: What Lab Tests May Be Used in Longevity Medicine? →, How Are Longevity Treatment Plans Personalized? →, and How Are Longevity Treatment Results Monitored Over Time? →

Peptides and Their Role in Longevity Research

Peptides are short chains of amino acids, the building blocks of proteins. Your body makes many of them, and several act as hormones or signaling molecules. Insulin and GLP-1, for example, are peptides, and some peptide drugs are well-established, FDA-approved medicines. "Longevity peptides" is a looser label for a group of compounds studied for effects on growth hormone signaling, cellular energy, tissue repair, inflammation, and skin.

Here is where the evidence stands in general. Many peptides show interesting effects in cell and animal studies. Human studies are far fewer, usually small and short, and they often measure biomarkers (like a blood level) rather than outcomes people feel or live with. A change in a biomarker does not prove a health benefit.

Regulation is a second source of confusion. FDA approval applies to a specific product for a specific use. Many peptides sold for longevity are prepared by compounding pharmacies for individual patients. Compounded medicines are not FDA-approved, and the FDA does not verify their safety or effectiveness before they are dispensed. (6) Your prescribing clinician decides, based on your individual medical needs, whether a compounded medicine is appropriate. The regulatory status of individual peptides also changes over time. For example, an FDA advisory committee made recommendations on several peptides in July 2026, but those recommendations are advisory only and do not by themselves make a peptide available for compounding. You can follow updates on Evergreen's peptide regulatory status page →.

Quality varies too, especially for products sold online as "research chemicals." For a plain-language explanation of what separates pharmacy-compounded peptides from unregulated products, read why peptide prices and quality vary so much →. And for the regulatory question in depth, see Are Longevity Peptide Treatments FDA-Approved? →.

GLP-1 Microdosing and Weight Maintenance

GLP-1 medications such as semaglutide and tirzepatide are approved at specific doses for weight management and type 2 diabetes. "Microdosing" refers to using doses lower than those approved or studied, often as a way to maintain weight after weight loss or to support metabolic health. There is no standard definition of a microdose, and no agreed schedule. (7)

The evidence gaps are significant. The weight-loss and cardiovascular benefits of semaglutide and tirzepatide come from clinical trials of approved doses, for example the SELECT trial, which linked semaglutide to fewer cardiovascular events in adults with overweight or obesity and existing heart disease. (8) Those results cannot be assumed to carry over to lower doses. Early research suggests GLP-1 medicines may influence inflammation and other aspects of health beyond weight, (30) but that research also comes from full-dose studies, and no long-term trials have tested whether low doses produce the same effects. Reviewers have also pointed out that products used for microdosing are usually compounded and have not been studied for safety, effectiveness, or weight regain after stopping. (7)

The maintenance question itself is real, though. In the extension of the STEP 1 trial, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year. (9) That is why many clinicians treat obesity as a long-term condition and consider an individualized maintenance plan. A 2026 randomized trial of tirzepatide (SURMOUNT-MAINTAIN) found that stepping down to 5 mg, an approved dose, kept off more weight than switching to placebo but less than continuing the maximum tolerated dose. (32) It does not mean that any specific low dose, or any dose below the approved range, works. A clinician should decide whether a lower dose, a slower schedule, or continued full dosing makes sense for you, and monitor the results. To see what a GLP-1 prescription typically involves, read What Should I Expect From a GLP-1 Prescription? →.

For the full picture on GLP-1 therapy, see The Complete Guide to GLP-1 Weight Loss Treatment →, Semaglutide vs. Tirzepatide →, and GLP-1 Weight Loss Treatment: How It Works →. If your main goal is weight loss, Evergreen Lean → is Evergreen's GLP-1 program. More on the microdosing question and weight maintenance is coming: Learn more about GLP-1 microdosing → and Why Weight Maintenance Matters for Long-Term Metabolic Health →.

Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity →

Sermorelin and Growth Hormone Signaling

Growth hormone (GH) is made by the pituitary gland in response to a signal from the brain called growth hormone-releasing hormone (GHRH). GH then prompts the liver and other tissues to make IGF-1, a hormone involved in growth and tissue repair. GH output declines with age, which is the reasoning behind interest in therapies that act on this pathway.

Sermorelin is a peptide that corresponds to the first 29 amino acids of GHRH. It acts on the pituitary to prompt the body to release its own growth hormone, rather than supplying growth hormone directly. That is different from injecting human growth hormone (HGH) itself. Sermorelin vs. HGH: What's the Difference? →

The regulatory history matters. Sermorelin was previously FDA-approved as a diagnostic agent (1990) and for children with growth failure from growth hormone deficiency (1997). The manufacturer discontinued it in 2008, and the FDA later determined the withdrawal was not for reasons of safety or effectiveness. (10) Today, sermorelin is available only as a compounded medication, which is not an FDA-approved drug product. Using it for longevity, sleep, or body composition in adults is off-label and investigational. It was not what the original approvals covered.

What does the research show? Older studies found that GHRH-based treatment can raise growth hormone and IGF-1 levels in older adults, but those studies were small and short. (11) For example, a 1992 study of twice-daily GHRH(1-29) in older men lasted two weeks. (11) Raising a hormone level is not the same as improving health, and there is no good evidence that sermorelin extends lifespan, reverses aging, or prevents age-related disease. Pediatric trials reported injection-site reactions and facial flushing as common side effects. (12)

Because growth hormone signaling affects cell growth and metabolism, a clinician should review your history before considering any therapy in this category. Learn more: What Is Sermorelin and How Does It Work? →, What Are the Potential Side Effects of Sermorelin? →, and the Sermorelin Treatment Guide →.

NAD+ and Cellular Energy

NAD+ (nicotinamide adenine dinucleotide) is a molecule found in every cell. It helps convert food into usable energy and supports enzymes involved in DNA repair. Levels in tissue appear to decline with age, which has driven interest in raising NAD+ as a healthy-aging strategy. (13)

The basic biology is solid. The treatment evidence is much thinner. Most human trials involve oral "precursors" such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which consistently raise blood NAD+ levels but have shown mixed, often null, effects on how people function. (14) A 2026 systematic review found no eligible outcome trials of intravenous or intramuscular NAD+ itself for anti-aging or wellness. (14) The first published human study of directly infused NAD+, a small 2019 pilot in 11 men, measured where NAD+ went in the body, not whether anyone felt or performed better. (15) A broader review concluded that only a small number of adequately powered randomized trials of NAD-boosting strategies exist. (16)

NAD+ injections are typically compounded, and NAD+ is not FDA-approved for any medical indication. Side effects reported are usually mild (nausea, headache, tiredness, redness at the injection site, or a brief flushing or "rush" feeling), and long-term safety data are limited. Some people report better energy or focus; without placebo-controlled trials, it is not possible to say how much comes from NAD+ itself.

Learn more: What Is NAD+ and Why Does It Matter for Cellular Health? →, What Should Patients Know About NAD+ Injections? →, and the NAD+ Treatment Guide →.

Glutathione and Antioxidant Function

Cells constantly produce reactive molecules as a byproduct of making energy. Left unchecked, these can damage proteins, fats, and DNA, a process called oxidative stress that is associated with aging and many chronic conditions. Glutathione, a small molecule your body makes from three amino acids, is one of the main antioxidants that keeps this in balance. Levels tend to fall with age and illness.

That biological role does not prove that taking more glutathione improves health. Trials of oral glutathione have had mixed results: one randomized trial found that oral glutathione raised measured body stores over six months, (17) while a four-week randomized trial in healthy adults found no significant changes in oxidative stress markers. (18) The best-studied use is skin lightening, where a 2025 systematic review found oral and topical forms had better evidence than intravenous glutathione, and found only one placebo-controlled IV study, which did not reach statistical significance. (19)

Safety deserves particular attention here. In August 2026, the FDA reported adverse events in at least 30 patients who received intravenous glutathione compounded from dietary supplement grade ingredient, which is not appropriate for making injectable drugs, and in a September update the CDC reported illnesses in several states. (20) The lesson is not that every glutathione product is unsafe. It is that the source and quality of a compounded injectable matter as much as the molecule. Glutathione is not FDA-approved as an injectable drug product.

Learn more: What Is Glutathione and What Does It Do? →, Understanding Cellular Aging and Oxidative Stress →, and NAD+ vs. Glutathione: How Are They Different? →.

GHK-Cu and Skin Health

GHK-Cu is a naturally occurring copper-binding tripeptide made of three amino acids. Its levels in the body appear to decline with age, and it has been studied for roles in wound healing and skin repair. In laboratory studies it stimulates collagen and other components of the skin's structure. (21)

In people, the evidence is almost entirely about topical use, meaning creams and serums applied to the skin. A handful of small human studies report modest improvements in the appearance of aging skin, such as firmness and fine lines. (21) Those studies are generally small, short, and often linked to the ingredient's developers or the cosmetics industry, and a recent reviewer described the clinical evidence as thinner than the marketing suggests. (21, 22) Evidence for GHK-Cu is thinner than for long-studied skin treatments.

Injectable GHK-Cu is a different matter. It has become popular in wellness circles, but there are no published human studies showing that injecting it is safe and effective. (22) This guide discusses the topical form, which is the one with human research.

Learn more: GHK-Cu Copper Peptides: What Does Research Say About Skin Aging? → and Topical GHK-Cu vs. Retinoids for Skin Aging →.

Low-Dose Naltrexone and Emerging Research

Naltrexone is an FDA-approved medication for alcohol and opioid use disorders, typically at doses of 50 mg or more. (23) Low-dose naltrexone (LDN) uses a much smaller dose, traditionally in the range of 1 to 5 mg. It is thought to work differently from the standard dose, briefly blocking certain receptors overnight, which prompts the body to produce more of its own endorphins and may calm inflammatory activity in the brain's immune cells. Those mechanisms are still being worked out in humans. (25)

Using naltrexone at low doses is off-label. The best-studied use is fibromyalgia: a 2024 meta-analysis of four randomized trials (222 patients) found a statistically significant reduction in pain scores compared with placebo, (24) but the largest and most rigorously designed trial found no pain benefit over placebo, (31) and reviewers describe the overall strength of evidence as limited because trials are small, short, and mostly in women. (25) LDN has been explored in other conditions, mostly in small or early studies. We found no study showing that LDN slows aging or extends lifespan.

Side effects are usually mild: vivid dreams, trouble sleeping, headache, or mild nausea. LDN cannot be taken with opioid medicines, and it is not used during pregnancy or breastfeeding or with serious liver disease. Learn more: Low-Dose Naltrexone: How It Works and What Is Being Studied →.

Safety, Eligibility, and Clinical Monitoring

Each longevity treatment has its own risks, so "is it safe?" has no single answer. A few examples show why one-size-fits-all protocols don't make sense:

  • GLP-1 medications are not used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome, and they require caution with a history of pancreatitis or gallbladder problems. They are not used during pregnancy. See What Are the Possible Side Effects of GLP-1s? → for more.
  • NAD+ is not used during pregnancy, breastfeeding, or active cancer treatment. It can lower blood pressure if the dose is too high, and it can interact with diabetes, blood pressure, depression, and blood-thinning medicines.
  • LDN cannot be combined with opioids, and it requires extra care with liver disease and thyroid medicine.
  • Sermorelin, glutathione, and GHK-Cu each have their own precautions, which is why a clinician reviews your history before any is considered.

Product quality adds another layer. Compounded medicines are not FDA-approved, and quality depends on the pharmacy, the ingredients, and the sterility controls used. (6) It is reasonable to ask where a medication is compounded, how it is tested, and how long it can be stored. Whether a compounded product is appropriate is a decision your prescriber makes for you individually.

Monitoring is how a plan is reviewed and adjusted over time. That can include follow-up check-ins about how you feel and any side effects, reviewing other medications, and ordering labs when they are clinically indicated. If something feels wrong, such as chest pain, trouble breathing, swelling of the face or throat, fainting, or severe symptoms of any kind, seek emergency care. Not every person will be a candidate for every treatment, and responsible care means saying no when a treatment does not fit.

Learn more: What Questions Should You Ask Before Starting Longevity Treatment? →, Can Multiple Longevity Treatments Be Used Together? →, and Understanding the Risks of Compounded Longevity Medications →.

The statements above have not been evaluated by the Food and Drug Administration. Evergreen products are not designed to diagnose, treat, cure, or prevent any medical condition. Before receiving a prescription, patients complete an online evaluation with a licensed physician. Whether a prescription is appropriate is a clinical determination made at that time. Certain products are prepared by a licensed compounding pharmacy. The FDA does not review or approve compounded formulations for safety, effectiveness, or quality. Full safety information is available on each individual product page. Any outcomes or benefits described on helloevergreen.com reflect independent, third-party research, and are not guarantees tied to Evergreen’s specific formulations unless stated otherwise. All medications are provided through a subscription model, and patients may cancel at any time prior to next refill. Product packaging received may vary from images shown on this website.

Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity →

Lifestyle Foundations for Healthy Aging

Here is the part of longevity science that is least glamorous and best supported. Habits, not prescriptions, have the strongest evidence behind them. In a large observational study of US adults, those who followed five healthy habits (not smoking, a healthy weight, regular physical activity, moderate alcohol intake, and a healthy diet) had a life expectancy at age 50 about 12 to 14 years longer than those who followed none. (26) Observational data show association, not proof, but the pattern is consistent with decades of other research.

  • Move, and lift. Adults need at least 150 minutes a week of moderate-intensity activity (or 75 minutes of vigorous activity) plus muscle-strengthening activity on at least 2 days a week. Older adults should add balance training. (27) Resistance training is the most reliable way to slow muscle loss. (4)
  • Eat enough protein and a pattern built on whole foods. The American Heart Association's checklist for cardiovascular health calls for a healthy eating pattern with fruits, vegetables, lean proteins, nuts, and seeds, along with limiting alcohol. (28) Your body also needs protein to build and maintain muscle. (4)
  • Protect your sleep. Adults generally need seven or more hours a night, and poor sleep affects appetite, recovery, mood, and metabolic health. (29)
  • Don't smoke, and keep up with preventive care. Not smoking, blood pressure, cholesterol, and blood sugar control are among the strongest levers for healthspan. (28)
  • Stay connected. Strong relationships and good mental health also contribute to a longer healthspan. (28)

No treatment replaces these. Where established evidence is strongest is covered in Longevity Peptides vs. Lifestyle Interventions →. If you are using a GLP-1 medication, protecting muscle matters even more, and you can read more in How to Protect Muscle While Losing Weight →.

Frequently Asked Questions

Do longevity treatments actually work?

It depends on the treatment and on what "work" means. Some approaches reliably change a biomarker, such as blood NAD+ levels or growth hormone levels, but changing a biomarker is not the same as extending life or improving health. For most longevity treatments, strong human trials showing better health outcomes are still missing. Lifestyle habits have the strongest evidence.

Can longevity treatments extend my lifespan?

No treatment has been proven to extend human lifespan. Researchers are studying many, but the human evidence is limited. A more realistic goal is supporting healthspan: staying strong, energetic, and independent. What Is Healthspan and How Is It Different from Lifespan? →

Are longevity peptides FDA-approved?

Generally no. Some peptides were once FDA-approved for specific medical uses, but using them for longevity is typically off-label, and compounded peptides are not FDA-approved products. Regulatory status changes, so check current information. Are Longevity Peptide Treatments FDA-Approved? →

Are longevity treatments safe?

Safety varies by treatment, dose, product quality, and the person taking it. Long-term data are limited for several of them, and some people should not use certain treatments at all. Medical oversight and ongoing monitoring are part of managing risk.

Can I combine more than one longevity treatment?

Sometimes clinicians combine therapies, but combinations are rarely studied, so any combination should be individualized and monitored. Adding treatments can add side effects and interactions. Can Multiple Longevity Treatments Be Used Together? →

How long does it take to notice a difference?

There is no reliable timeline, and responses vary a lot. Some people notice changes within weeks and others notice nothing. Because many effects are subtle and hard to separate from placebo or lifestyle changes, regular check-ins with your clinician matter. How Long Does It Take to Notice Changes From Longevity Treatments? →

Learn More About Evergreen Longevity

If you want clinician-guided care, Evergreen Longevity is Evergreen's program for healthy aging. A licensed provider reviews your health history and goals and decides which approaches, if any, are appropriate for you. Not every treatment described in this guide is available to every patient, and a licensed provider makes that decision for each person. For program details, see the Evergreen Longevity page, and meet the clinicians behind Evergreen's programs on the About page →.

Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity →

References

1. Healthspan-lifespan gap:
Garmany A, Terzic A. Global healthspan-lifespan gaps among 183 World Health Organization member states. JAMA Netw Open. 2024;7(12):e2450241. https://pubmed.ncbi.nlm.nih.gov/39661386/

2. Genetics and lifespan:
Harvard Health Publishing. Lifespan vs. healthspan: why how you age matters more than how long you live. https://www.health.harvard.edu/healthy-aging-and-longevity/lifespan-vs-healthspan-why-how-you-age-matters-more-than-how-long-you-live

3. Muscle loss with age:
Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. https://pmc.ncbi.nlm.nih.gov/articles/PMC2804956/

4. Sarcopenia, resistance training, and protein:
NIH News in Health. Slowing sarcopenia. April 2025. https://newsinhealth.nih.gov/2025/04/slowing-sarcopenia

5. Muscle peak and decline:
National Institute on Aging. How can strength training build healthier bodies as we age? https://www.nia.nih.gov/news/how-can-strength-training-build-healthier-bodies-we-age

6. Compounded drugs and FDA approval:
U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

7. GLP-1 microdosing lacks a definition and evidence:
STAT. GLP-1 microdosing is popular, but there's little evidence it works. May 29, 2026. https://www.statnews.com/2026/05/29/glp-1-microdose-popular-but-unsupported-by-evidence/

8. Cardiovascular outcomes with semaglutide:
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/

9. Weight regain after stopping semaglutide:
Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/

10. Sermorelin regulatory history:
U.S. Food and Drug Administration. Determination that sermorelin acetate injection products were not withdrawn from sale for reasons of safety or effectiveness. Federal Register. March 4, 2013. https://www.federalregister.gov/documents/2013/03/04/2013-04827/determination-that-geref-sermorelin-acetate-injection-05-milligrams-basevial-and-10-milligrams

11. GHRH(1-29) in older men:
Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-535. https://pubmed.ncbi.nlm.nih.gov/1379256/

12. Sermorelin pediatric safety:
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. https://pubmed.ncbi.nlm.nih.gov/18031173/

13. NAD+ decline with age:
Reyna K, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026. https://pubmed.ncbi.nlm.nih.gov/41704678/

14. NAD+ evidence review:
Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026. PMID 41655607. https://pubmed.ncbi.nlm.nih.gov/41655607/

15. Infused NAD+ in humans:
Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257. https://pubmed.ncbi.nlm.nih.gov/31572171/

16. NAD clinical trial landscape:
Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals (Basel). 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7558103/

17. Oral glutathione and body stores:
Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. https://pubmed.ncbi.nlm.nih.gov/24791752/

18. Oral glutathione and oxidative stress markers:
Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827-833. https://pmc.ncbi.nlm.nih.gov/articles/PMC3162377/

19. Glutathione for skin lightening:
Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025;64(6):992-1004. https://pubmed.ncbi.nlm.nih.gov/39444151/

20. Compounded injectable glutathione safety alert:
U.S. Food and Drug Administration. FDA reminds compounders not to use dietary supplement grade glutathione for injectables. August 27, 2026. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables ; Centers for Disease Control and Prevention. Adverse events linked to injectable glutathione compounded with dietary supplement grade ingredient: current situation. Updated September 15, 2026. https://www.cdc.gov/healthcare-associated-infections/current-situation/index.html

21. GHK-Cu laboratory and clinical research:
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/

22. Topical vs injectable GHK-Cu:
NPR. The copper peptide trend has gone from creams to injections, ahead of the science. September 7, 2026. https://www.npr.org/2026/09/07/nx-s1-5955552/copper-peptides-skin-aging-health-safe

23. Naltrexone approvals and LDN in fibromyalgia:
Yang J, Shin KM, Do A, et al. The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10039621/

24. LDN meta-analysis:
Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11450306/

25. LDN strength of evidence and mechanism:
A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. https://pmc.ncbi.nlm.nih.gov/articles/PMC10189400/

26. Healthy lifestyle and life expectancy:
Li Y, Pan A, Wang DD, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 2018;138(4):345-355. https://pubmed.ncbi.nlm.nih.gov/29712712/

27. Physical activity guidelines:
U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition; CDC. Physical activity for adults. https://www.cdc.gov/physical-activity-basics/guidelines/adults.html

28. Healthspan and cardiovascular health habits:
American Heart Association. What is healthspan, and how can you maximize yours? January 14, 2025. https://www.heart.org/en/news/2025/01/14/what-is-healthspan-and-how-can-you-maximize-yours

29. Sleep duration for adults:
Centers for Disease Control and Prevention. About sleep. https://www.cdc.gov/sleep/about/index.html

30. Inflammatory markers with semaglutide (as cited in Evergreen's GLP-1 Main Guide):
Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021;325(14):1403-1413. https://pubmed.ncbi.nlm.nih.gov/33625476/

31. LDN in fibromyalgia, largest placebo-controlled trial:
Due Bruun K, Christensen R, Amris K, et al. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2024;6(1):e31-e39. https://pubmed.ncbi.nlm.nih.gov/38258677/

32. Dose reduction for weight maintenance:
Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. 2026. https://pubmed.ncbi.nlm.nih.gov/42119587/

This page is for educational purposes only and is not a substitute for individualized medical advice. Always consult a licensed healthcare provider before starting or stopping any medication. Information and statements on this material have not been evaluated by the Food and Drug Administration. Evergreen Telehealth content is for general education and should never replace professional medical advice that considers your individual health.

Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth, on November 17, 2026.

The statements above have not been evaluated by the Food and Drug Administration. Evergreen products are not designed to diagnose, treat, cure, or prevent any medical condition. Before receiving a prescription, patients complete an online evaluation with a licensed physician. Whether a prescription is appropriate is a clinical determination made at that time. Certain products are prepared by a licensed compounding pharmacy. The FDA does not review or approve compounded formulations for safety, effectiveness, or quality. Full safety information is available on each individual product page. Any outcomes or benefits described on helloevergreen.com reflect independent, third-party research, and are not guarantees tied to Evergreen’s specific formulations unless stated otherwise. All medications are provided through a subscription model, and patients may cancel at any time prior to next refill. Product packaging received may vary from images shown on this website.